Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Journal of Thrombosis and Haemostasis : JTH
|
July 7, 2018
Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults
M-L Piel-Julian, M Mahévas, J Germain, et al.
Leukemia
|
August 24, 2007
Human telomerase is regulated by erythropoietin and transforming growth factor-beta in human erythroid progenitor cells
N Prade-Houdellier, E Frébet, C Demur, et al.
Leukemia
|
July 11, 2008
Spontaneous and Fas-induced apoptosis of low-grade MDS erythroid precursors involves the endoplasmic reticulum
E Gyan, E Frisan, O Beyne-Rauzy, et al.
Leukemia
|
April 16, 2011
Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias
R Itzykson, O Kosmider, T Cluzeau, et al.
Leukemia Research
|
August 2, 2011
Ferritin level at diagnosis is not correlated with poorer survival in non RBC transfusion dependent lower risk de novo MDS
S Park, R Sapena, C Kelaidi, et al.
British Journal of Haematology
|
May 10, 2006
High-dose darbepoetin alpha in the treatment of anaemia of lower risk myelodysplastic syndrome results of a phase II study
L Mannone, C Gardin, M C Quarre, et al.
Leukemia Research
|
December 20, 2011
Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine?
R Itzykson, S Thépot, O Beyne-Rauzy, et al.
Leukemia
|
February 2, 2013
Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents
C Kelaidi, S Park, R Sapena, et al.
Leukemia
|
January 20, 2009
Is there a role for all-trans retinoic acid in combination with recombinant erythropoetin in myelodysplastic syndromes? A report on 59 cases
R Itzykson, S Ayari, D Vassilief, et al.
Leukemia Research
|
June 30, 2015
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes
G Caocci, M T Voso, E Angelucci, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Journal of Thrombosis and Haemostasis : JTH
|
July 7, 2018
Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults
M-L Piel-Julian, M Mahévas, J Germain, et al.
Leukemia
|
August 24, 2007
Human telomerase is regulated by erythropoietin and transforming growth factor-beta in human erythroid progenitor cells
N Prade-Houdellier, E Frébet, C Demur, et al.
Leukemia
|
July 11, 2008
Spontaneous and Fas-induced apoptosis of low-grade MDS erythroid precursors involves the endoplasmic reticulum
E Gyan, E Frisan, O Beyne-Rauzy, et al.
Leukemia
|
April 16, 2011
Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias
R Itzykson, O Kosmider, T Cluzeau, et al.
Leukemia Research
|
August 2, 2011
Ferritin level at diagnosis is not correlated with poorer survival in non RBC transfusion dependent lower risk de novo MDS
S Park, R Sapena, C Kelaidi, et al.
British Journal of Haematology
|
May 10, 2006
High-dose darbepoetin alpha in the treatment of anaemia of lower risk myelodysplastic syndrome results of a phase II study
L Mannone, C Gardin, M C Quarre, et al.
Leukemia Research
|
December 20, 2011
Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine?
R Itzykson, S Thépot, O Beyne-Rauzy, et al.
Leukemia
|
February 2, 2013
Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents
C Kelaidi, S Park, R Sapena, et al.
Leukemia
|
January 20, 2009
Is there a role for all-trans retinoic acid in combination with recombinant erythropoetin in myelodysplastic syndromes? A report on 59 cases
R Itzykson, S Ayari, D Vassilief, et al.
Leukemia Research
|
June 30, 2015
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes
G Caocci, M T Voso, E Angelucci, et al.
Page
of 3